Janssen Research and Development, L.L.C., a member of Johnson and Johnson's Family of Companies, is recruiting for a VP, Compound Development Team Leader (CDTL), to be located in Spring House, PA.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found.
As Immunology Leaders, we know immunology is vital to human health. Driven by a relentless focus on patient unmet needs, we will redefine treatments for immune diseases by delivering transformational and accessible therapies and regimens to patients with immune-mediated disease. For more than two decades we have been a world leader in the development of transformational medicines, establishing one of the strongest, first-in-class portfolios and pipelines in the industry, including the first tumor necrosis factor (TNF) inhibitor, and first interleukin (IL)-12 and IL-23 inhibitors. We tirelessly push the boundaries of science and creativity, applying our deep disease insights, novel pathway science, new technologies, and treatment modalities to restore immune homeostasis.
Janssen Research & Development, LLC. discovers and develops innovative medical solutions to address important unmet medical needs in the following therapeutic areas: immunology, oncology, neuroscience, infectious diseases & vaccines, cardiovascular & metabolism, and pulmonary hypertension. Please visit http://www.JanssenRnD.com for more information.
We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it. We are guided by our Credo.
Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer.
The VP, Compound Development Team Leader (CDTL) will work within the Portfolio and Asset Management (P&AM) Team. The P&AM Team is a unique and diverse team of scientific and innovative leaders responsible for driving dynamic drug development to create a competitive advantage through strategic program and asset management serving to build and deliver the global immunology portfolio for patients. In addition to the CDTLs, the P&AM team is also responsible for executing on the portfolio strategy for immunology and delivering on the business operations, including external alliances.
The VP, Compound Development Team Leader (CDTL) leads a cross-functional compound development team to maximize the value of the asset and drives execution of the compound strategy. The CDTL champions the project(s) at all levels of J&J through providing clear communication, creative strategic approaches to development and securing appropriate resources to deliver on the milestones.
Responsibilities include but are not limited to:
· Leads the overall asset strategy, that may include multiple indications managed by CDTLs who are assigned to lead each of the program teams. Multiple indications will require alignment with multiple DAS leaders and members of the TA leadership team (TALT).
· Lead the development and execution of the compound development strategy for the program(s), creating a vision for each compound within the Therapeutic Area (TA) portfolio, including identifying potential indication to be pursued and sequencing of these indications.
· Lead the asset level Compound Development Team (CDT) with representation from appropriate functional partners, to create an Integrated Development plan that provides a thorough and clear asset strategy by:
Integrating input from all functional areas to identify key development issues and the strategic approach to each, with associated timelines and budgets and providing clarity on alternative pathways and tradeoffs considered.
o Creating the target product profiles in collaboration with commercial, market access, medical affairs and clinical groups and adjusting this profile as new information and insights are gained.
o Driving decision-making on compound late lifecycle strategy, ensuring relevant research, analysis, competitive data, and expertise are taken into account.
o Leading discussions at the CDT to reach decisions, including making final decisions when full consensus cannot be reached.
o Challenging functional representatives to ensure that all issues and questions are being addressed, and that functional area input into the strategy is adequate to meet the needs of the compound.
o Managing the complexity of internal/external development and commercial activities and proactively identifying issues and risks while leading contingency planning and problem solving.
o Ensuring development and implementation of optimal IP, medical affairs, publication and regulatory strategies to protect and maximize asset value.
o Collaborating closely with the PML on the asset to identify and plan fit-for-purpose resources (FTEs and budget) to support the program.
o Ensuring adequate project resource utilization and budget management, providing clarity and transparency on changes and potential tradeoffs.
o Mentoring and coaching assigned team members to lead sub-teams and other Development Programs as required.
· Ensuring team alignment with Leadership and executing on feedback with regard to Go/No Go decisions, timelines, key activities, resource allocations and budgets, valuations and prioritization.
· Driving strategic alignment for development, medical affairs, commercial, pricing & market access plans.
· Presenting strategic options and leading phase transition proposals at governance boards.
· Maintaining a focus on pipeline value rather than single project value and balancing the role as team leader with a commitment to maximizing portfolio value by supporting Go decisions and appropriately arriving at No Go decisions.
· Playing an active role as a member of the CDTL community to helping lead and devise strategies for key strategic initiatives and talent development across the Portfolio.
· Representing the CDT on various cross functional committees.
· Leading cross functional/therapeutic area/company initiatives outside of assigned CDT.
· Participating in portfolio/strategy committees
· Potential to perform the above tasks for business development opportunities.
· Guide and mentor program level CDTLs so that they can have individual career development plans.
• Deep understanding of the unmet need addressed by the asset; scientific/disease areas expertise as well as expertise in current and innovative therapeutic development paradigms
• Ability to integrate all cross functional disciplines into a successful strategy
• Strong problem-solving skills for developing creative solutions and meeting project objectives
• Influence, negotiation and conflict resolution skills, including the ability to influence without clear reporting authority
• Ability to identify and manage all stakeholders, including at the most senior levels in the organization
• Demonstrated ability of strategic thinking and contingency planning
• Deep understanding of requirements for successful commercialization of a new product, including competitive and payer landscape across different geographies and pricing strategies
• Strategic Agility: Understanding big picture for compound and Janssen portfolio, translating scientific and business concepts into short and long-term deliverables, managing ambiguity and making decisions with incomplete data
Advanced Degree (e.g. Ph.D., M.D., or Pharm.D.,) with at least 12-15 years of pharmaceutical industry experience is required
Regulatory submissions experience is desired
Experience in a leadership role as part of a research-driven pharmaceutical company is required
Experience in cross-functional team leadership, including strategy development and driving tactical delivery of programs is required
Experience in influence, negotiation and conflict resolution skills, including the ability to influence without reporting authority are required
Outstanding leadership and communication skills are required
Experience with drug development in Immunology is preferred
Alliance management experience is a plus
Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
The anticipated base pay range for this position is $243,000 to $446,200.